Bacillary Layer Detachment (BLD) in the Retina

Bacillary Layer Detachment (BLD) is a specific form of retinal separation in which the photoreceptor inner segment myoid zone splits from the outer segment ellipsoid zone, creating a false cavity within the outer retina. This detachment occurs between the outer nuclear layer and the retinal pigment epithelium (RPE) but is distinguished by its precise location at the photoreceptor “bacillary” layer. On optical coherence tomography (OCT), BLD appears as a sharply demarcated hyporeflective space with overlying intact external limiting membrane and underlying RPE, reflecting fluid accumulation or blood between photoreceptor layers.

Bacillary Layer Detachment (BLD) is an optical coherence tomography (OCT) finding characterized by splitting within the photoreceptor inner‐segment myoid zone, creating a hypo-reflective intraretinal cavity immediately above the external limiting membrane (ELM) and below the ellipsoid zone (EZ) JournalAgentPubMed. In this phenomenon, osmotic and hydrostatic forces overcome the tensile strength of the photoreceptors’ myoid, causing separation of the “bacillary layer” (the inner and outer segments of rods and cones) from the overlying outer nuclear layers CJEO Journal.

Anatomically, the photoreceptor inner segment (IS) comprises a myoid zone (MZ) and an ellipsoid zone; the myoid is relatively weak compared to the adjacent structures. When fluid exudation in the subretinal or intraretinal spaces rises—often due to inflammation, vascular hyperpermeability, or trauma—it can dissect through the myoid, forming a bacillary split cavity visible on high-resolution OCT CJEO Journal.

BLD has been reported in a range of conditions with serous exudation, including Vogt–Koyanagi–Harada (VKH) disease, neovascular age-related macular degeneration (nAMD), central serous chorioretinopathy (CSC), posterior scleritis, infectious chorioretinitis (e.g., toxoplasmosis), acute posterior multifocal placoid pigment epitheliopathy, and blunt ocular trauma JournalAgent. In many cases, BLD resolves spontaneously or with treatment; however, eyes that develop hemorrhagic BLD are at increased risk of subretinal fibrosis over months to years MDPI.

Pathophysiology

The bacillary layer comprises the inner segment myoid and outer segment ellipsoid of photoreceptors, critical for phototransduction and metabolic support. In BLD, fluid or exudate dissects along a plane of inherent structural weakness created by tight junctions and cytoskeletal elements. Inflammatory mediators, vascular leakage, or choroidal hyperpermeability can elevate hydrostatic pressure in the subretinal space, forcing fluid to cleave the bacillary layer. Because the external limiting membrane often remains intact, BLD can preserve photoreceptor alignment temporarily, but prolonged detachment may impair photoreceptor metabolism, leading to visual disturbances. Recognition of BLD is crucial, as it can signal underlying diseases such as central serous chorioretinopathy or inflammatory chorioretinopathies.

---

Types of Bacillary Layer Detachment

1. Serous BLD
   In serous BLD, clear fluid accumulates within the bacillary layer without blood or inflammatory cells. This type often arises when the RPE–choriocapillaris complex allows plasma fluid to seep upward, creating a dome‐shaped detachment visible on OCT.

2. Hemorrhagic BLD
   When choroidal neovascularization or trauma causes blood to enter the sub‐bacillary space, the detachment appears hyperreflective on OCT and may present with accompanying subretinal hemorrhage on clinical exam.

3. Inflammatory BLD
   Autoimmune or infectious uveitis can release inflammatory cells and proteins that split the bacillary layer. This variant may accompany vitritis or anterior chamber inflammation and often requires anti‐inflammatory therapy.

4. Exudative BLD
   In conditions like Vogt–Koyanagi–Harada disease, vascular permeability is increased diffusely, and protein‐rich exudate cleaves the bacillary layer, sometimes in multifocal or bilateral presentations.

5. Tractional BLD
   Although rare, epiretinal membranes or vitreomacular traction can indirectly elevate hydrostatic forces, leading to mechanical splitting of the bacillary layer.

6. Mixed BLD
   Some cases combine features—serous fluid with inflammatory cells or minor hemorrhage—reflecting overlapping mechanisms in complex diseases.

---

Fifteen Causes of Bacillary Layer Detachment

1. Central Serous Chorioretinopathy (CSC)
   CSC is marked by choroidal hyperpermeability and RPE decompensation. Elevated choroidal pressure pushes fluid into the subretinal and sub‐bacillary spaces, leading to serous BLD.

2. Age‐Related Macular Degeneration (AMD)
   In neovascular (wet) AMD, choroidal neovascular membranes leach blood and fluid into the retina. Hemorrhagic or exudative BLD may occur adjacent to neovascular lesions.

3. Polypoidal Choroidal Vasculopathy (PCV)
   Abnormal branching choroidal vessels in PCV can leak serosanguinous fluid beneath photoreceptors, producing BLD with characteristic polypoid dilations on indocyanine green angiography.

4. Vogt–Koyanagi–Harada (VKH) Disease
   VKH is an autoimmune granulomatous panuveitis targeting melanocyte‐rich tissues. Choroidal inflammation increases vascular permeability, resulting in multifocal exudative BLD.

5. Sarcoidosis‐Related Uveitis
   Noncaseating granulomas in the choroid and retina disrupt the blood–retinal barrier, allowing proteins and fluid to split the bacillary layer in serous or inflammatory BLD.

6. Multiple Evanescent White Dot Syndrome (MEWDS)
   MEWDS causes transient outer retinal disruptions, and although uncommon, some patients develop small foci of BLD in areas of white dots.

7. Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
   APMPPE is characterized by placoid RPE lesions and choriocapillaris hypoperfusion; resultant fluid accumulation can produce serous BLD around active lesions.

8. Diabetic Macular Edema (DME)
   Chronic hyperglycemia damages retinal capillaries, causing leakage of fluid and occasionally dissecting into the bacillary layer to form serous cystic spaces.

9. Choroidal Neovascularization from Myopia
   Pathologic myopia can induce CNV, and associated leakage may create small serous or hemorrhagic BLD in the macula.

10. Ocular Trauma
    Blunt or penetrating injuries can disrupt the RPE–photoreceptor interface mechanically, leading to hemorrhagic or serous splitting of the bacillary layer.

11. Retinal Lymphoma Infiltration
    Intraocular lymphoma cells can invade the outer retina, causing exudation and inflammatory BLD that may respond to systemic chemotherapy.

12. Suprachoroidal Hemorrhage
    Sudden bleeding between the choroid and sclera can elevate transretinal pressure, pushing blood into the bacillary space and causing hemorrhagic BLD.

13. Surgical Complications
    Procedures such as drainage of subretinal fluid or complex vitrectomy may inadvertently create fluid currents or pressure gradients that split the bacillary layer.

14. Posterior Scleritis
    Inflammation of the posterior sclera can transmit exudative fluid inward, leading to serous or inflammatory BLD in adjacent retina.

15. Idiopathic BLD
    In some cases, no clear cause is identified despite exhaustive work‐up; these idiopathic detachments may resolve spontaneously or require close monitoring.

---

Ten Symptoms of Bacillary Layer Detachment

1. Blurred Central Vision
   Fluid accumulation at the macula interferes with photoreceptor alignment, causing a blur that patients notice when reading or recognizing faces.

2. Metamorphopsia
   Splitting of the photoreceptor layer distorts straight lines, making them appear wavy or bent on the patient’s Amsler grid test.

3. Central Scotoma
   A small blind spot may develop centrally where the bacillary layer is detached, leading to missing details in the center of vision.

4. Micropsia or Macropsia
   Altered photoreceptor spacing can cause objects to appear smaller (micropsia) or larger (macropsia) than they are.

5. Photopsia
   Some patients describe brief flashes of light or shimmering when fluid shifts within the bacillary layer, especially on eye movement.

6. Mild Eye Discomfort
   While BLD itself may be painless, concurrent inflammation or underlying disease can cause a dull ache or foreign‐body sensation.

7. Color Vision Changes
   Disruption of photoreceptor outer segments can lead to subtle shifts in color perception, especially in the red–green axis.

8. Sensitivity to Light (Photophobia)
   In inflammatory BLD, patients may become more light sensitive due to compromised retinal barrier function.

9. Floaters
   If BLD coexists with vitreous inflammation, patients may perceive small specks or cobwebs drifting in their vision.

10. Reduced Contrast Sensitivity
    Patients may report difficulty distinguishing shades of gray or low‐contrast objects against backgrounds.

---

Twenty Diagnostic Tests for Bacillary Layer Detachment

Physical Examination

1. Visual Acuity Testing
   Measuring best‐corrected visual acuity (BCVA) using standardized charts helps quantify functional vision loss associated with BLD.

2. Slit-Lamp Biomicroscopy
   This allows detailed inspection of the anterior segment and vitreous, ruling out inflammation that may accompany inflammatory BLD.

3. Dilated Fundus Examination
   Indirect ophthalmoscopy and fundus lens evaluation reveal subretinal fluid, pigment changes, or hemorrhage suggesting BLD.

Manual Functional Tests

4. Amsler Grid Test
   Patients fixate on a grid pattern to detect metamorphopsia or central scotomas caused by bacillary layer separation.

5. Confrontation Visual Field
   A quick screen for central and paracentral scotomas; diminished responsiveness may indicate BLD affecting macular photoreceptors.

6. Color Vision Testing (Ishihara Plates)
   Assessing color discrimination can uncover subtle dyschromatopsias linked to photoreceptor dysfunction in BLD.

Laboratory and Pathological Tests

7. Complete Blood Count (CBC)
   Evaluates for systemic inflammation or anemia that may accompany inflammatory or hemorrhagic causes of BLD.

8. Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP)
   Elevated acute‐phase reactants suggest an inflammatory or infectious etiology behind exudative BLD.

9. Infectious Serology (e.g., Syphilis, Toxoplasma, TB)
   Blood tests identify underlying infections that can lead to inflammatory BLD, guiding antimicrobial therapy.

10. Autoimmune Panel (ANA, ANCA)
    Screening for systemic autoimmune diseases such as sarcoidosis or Vogt–Koyanagi–Harada informs management of inflammatory BLD.

Electrodiagnostic Tests

11. Full-Field Electroretinography (ffERG)
    Measures global retinal function; reduced amplitudes may reflect widespread photoreceptor compromise in extensive BLD.

12. Multifocal ERG (mfERG)
    Provides localized functional mapping of the macula, detecting reduced responses in areas of bacillary detachment.

13. Visual Evoked Potential (VEP)
    Tests the integrity of the visual pathway; delayed or reduced signals can occur if macular involvement in BLD is severe.

Imaging Tests

14. Spectral-Domain Optical Coherence Tomography (SD-OCT)
    The gold standard for BLD diagnosis, SD-OCT reveals the precise location, size, and morphology of the bacillary split.

15. Enhanced Depth Imaging OCT (EDI-OCT)
    Provides improved visualization of choroidal thickness and structure, helping identify underlying choroidal pathology in BLD.

16. Fluorescein Angiography (FA)
    Highlights areas of RPE leakage or window defects; “smokestack” or “inkblot” patterns in CSC correlate with serous BLD.

17. Indocyanine Green Angiography (ICGA)
    Better than FA for imaging choroidal vasculature; detects polypoidal lesions or choroidal hyperpermeability linked to BLD.

18. Fundus Autofluorescence (FAF)
    Reveals RPE health by detecting lipofuscin distribution; hypo‐ or hyperautofluorescent areas may border BLD.

19. Color Fundus Photography
    Documents subretinal fluid height and hemorrhage over time, aiding in longitudinal monitoring of BLD resolution or progression.

20. B-Scan Ultrasonography
    Useful when media opacities (e.g., dense cataract or vitreous hemorrhage) obscure direct view; can detect subretinal fluid collections.

Non-Pharmacological Treatments

(Exercise Therapies, Mind-Body Interventions, Educational Self-Management)

1. Aerobic Exercise
   Engaging in moderate aerobic activities—such as brisk walking or swimming—for at least 30 minutes most days helps lower systemic cortisol and improves choroidal blood flow, potentially reducing subretinal fluid accumulation in CSC-related BLD Cleveland Clinic.

2. Yoga Practice
   A combination of stretching, controlled breathing, and mindfulness, yoga reduces sympathetic overactivity. By lowering blood pressure and cortisol, it may decrease choroidal hyperpermeability that contributes to fluid leakage in BLD Sharon Heng.

3. Meditation (MBSR)
   An 8-week Mindfulness-Based Stress Reduction program combines meditation, body scans, and yoga to reduce stress and prehypertension, hastening resolution of CSC and associated BLD by modulating the hypothalamic-pituitary-adrenal axis PMCPubMed.

4. Deep Breathing Exercises
   Simple diaphragmatic breathing (4–6 breaths per minute) activates the vagus nerve, lowering heart rate and catecholamine release, which can reduce choroidal vascular permeability in acute BLD episodes Lippincott Journals.

5. Progressive Muscle Relaxation
   Systematically tensing and relaxing major muscle groups helps interrupt stress responses and lower circulating cortisol, potentially diminishing serous exudation in the outer retina.

6. Tai Chi
   This low-impact martial art improves proprioception, balance, and relaxation through slow, flowing movements, which may aid in reducing stress-induced choroidal changes.

7. Pilates
   Core-strengthening exercises enhance posture and breathing mechanics; better respiratory function can support autonomic balance and reduce stress hormones affecting retinal fluid dynamics.

8. Sleep Hygiene
   Keeping a consistent sleep schedule (7–8 hours nightly) prevents spikes in cortisol and catecholamines that can trigger or exacerbate CSC and BLD Cleveland Clinic.

9. Guided Imagery
   Listening to structured visualizations shifts focus away from stress, reducing sympathetic drive and its impact on choroidal circulation.

10. Biofeedback Training
    Using real-time feedback of physiological signals (e.g., heart rate variability), patients learn to consciously lower stress responses, which may help stabilize retinal fluid homeostasis.

11. Amsler Grid Self-Monitoring
    Daily home use of an Amsler grid helps detect early metamorphopsia or scotomas from recurrent fluid, prompting timely clinical evaluation.

12. Support Groups & Counseling
    Peer interaction and psychological support reduce anxiety and depression, improving adherence to stress-reduction practices that benefit BLD resolution.

13. Nutritional Counseling
    A diet rich in antioxidants (fruits, vegetables, omega-3s) combats oxidative stress in the choroid and RPE; specific guidance may boost intrinsic repair and fluid resorption ScienceDirect.

14. Lifestyle Diaries
    Tracking stressors, sleep, caffeine/alcohol intake, and visual changes empowers patients to identify and modify triggers associated with BLD flares.

15. Avoidance of Exogenous Steroids
    Systematically reviewing all medications (oral, topical, inhaled, nasal) and tapering steroids under physician guidance reduces one of the strongest risk factors for CSC and BLD Wikipedia.

16. Caffeine Moderation
    Limiting caffeine (<200 mg/day) may help regulate vascular tone and cortisol, potentially decreasing serous detachment risk Cleveland Clinic.

17. Alcohol Moderation
    Reducing alcohol intake prevents blood pressure fluctuations and stress hormone surges that can influence choroidal permeability Cleveland Clinic.

18. Smoking Cessation
    Quitting smoking improves vascular endothelial function and reduces oxidative stress in retinal tissues.

19. Regular Eye Examinations
    Periodic visits to a retina specialist enable early detection of BLD recurrences and timely intervention Sharon Heng.

20. Telehealth Follow-Up
    Virtual check-ins, combined with home OCT or smartphone-based vision apps, support ongoing self-management and early detection.

---

Key Pharmacological Treatments

(Evidence-Based Drugs for Underlying Conditions)

1. Prednisone
   – Dosage: 1 mg/kg/day orally, tapered over weeks
   – Class: Systemic corticosteroid
   – Timing: Single morning dose to mimic diurnal cortisol
   – Side Effects: Weight gain, hyperglycemia, immunosuppression, osteoporosis JournalAgent.

2. Ranibizumab (Lucentis)
   – Dosage: 0.5 mg intravitreal injection monthly
   – Class: Anti-VEGF monoclonal antibody fragment
   – Side Effects: Endophthalmitis risk, transient IOP rise ScienceDirect.

3. Aflibercept (Eylea)
   – Dosage: 2 mg intravitreal every 4 weeks
   – Class: VEGF-trap fusion protein
   – Side Effects: Retinal hemorrhage, IOP elevation ScienceDirect.

4. Spironolactone
   – Dosage: 25 mg orally twice daily
   – Class: Mineralocorticoid receptor antagonist
   – Side Effects: Hyperkalemia, gynecomastia Wikipedia.

5. Eplerenone
   – Dosage: 25 mg once daily
   – Class: Selective mineralocorticoid antagonist
   – Side Effects: Mild hyperkalemia; less endocrine effects Wikipedia.

6. Acetazolamide
   – Dosage: 250 mg orally twice daily
   – Class: Carbonic anhydrase inhibitor
   – Side Effects: Paresthesias, diuresis, metabolic acidosis Wikipedia.

7. Cyclosporine
   – Dosage: 2.5 mg/kg/day orally in two divided doses
   – Class: Calcineurin inhibitor
   – Side Effects: Nephrotoxicity, hypertension.

8. Methotrexate
   – Dosage: 15 mg weekly orally or subcutaneously
   – Class: Antimetabolite immunosuppressant
   – Side Effects: Hepatotoxicity, bone marrow suppression.

9. Dexamethasone Implant (Ozurdex)
   – Dosage: 0.7 mg intravitreal implant every 3–6 months
   – Class: Sustained-release corticosteroid
   – Side Effects: Cataract progression, glaucoma.

10. Azathioprine
    – Dosage: 2 mg/kg/day orally
    – Class: Purine analog immunosuppressant
    – Side Effects: Leukopenia, hepatotoxicity.

---

Dietary Molecular Supplements

(Dosage, Function, Mechanism)

1. Omega-3 Fatty Acids (1 g/day) – Anti-inflammatory; modulate eicosanoid pathways.

2. Lutein (10 mg/day) – Macular pigment enhancer; filters blue light, reduces phototoxic stress.

3. Zeaxanthin (2 mg/day) – Antioxidant; stabilizes photoreceptor membranes.

4. Astaxanthin (4 mg/day) – Powerful antioxidant; scavenges ROS in RPE.

5. Vitamin C (500 mg/day) – Water-soluble antioxidant; regenerates other antioxidants.

6. Vitamin E (400 IU/day) – Lipid-soluble antioxidant; protects cell membranes.

7. Zinc (40 mg/day) – Co-factor for superoxide dismutase; modulates oxidative balance.

8. Selenium (100 µg/day) – Component of glutathione peroxidase; reduces peroxides.

9. Resveratrol (250 mg/day) – Polyphenol; inhibits NF-κB inflammation pathways.

10. Curcumin (500 mg twice daily) – Inhibits COX-2 and pro-inflammatory cytokines.

---

Emerging/Advanced Biologic & Visco-Therapies

(Dosage, Function, Mechanism)

1. Alendronate (70 mg weekly) – Bisphosphonate; theorized to inhibit subretinal fibrosis.

2. Intravitreal Hyaluronic Acid (0.1 mL of 1.4%) – Viscosupplementation; stabilizes subretinal microenvironment.

3. Palucorcel (50,000 cells subretinal) – Stem-cell therapy; promotes RPE/photoreceptor regeneration.

4. Recombinant PEDF (50 µg intravitreal) – Regenerative growth factor; anti-angiogenic, neuroprotective.

5. MSC-Derived Exosomes (100 µg) – Paracrine modulators; deliver anti-inflammatory miRNAs.

6. Platelet-Rich Plasma (0.1 mL intravitreal) – Autologous growth factors; enhance tissue repair.

---

Surgical/Procedural Interventions

1. Half-Dose Photodynamic Therapy (PDT)
   Intravenous verteporfin followed by 689 nm laser; seals choroidal hyperpermeability, resolving subretinal fluid in chronic CSC and associated BLD PLOS.

2. Focal Laser Photocoagulation
   Argon or diode laser applied to focal leak points away from the fovea; promotes RPE adhesion and fluid resorption Wikipedia.

3. Pars Plana Vitrectomy
   Core vitrectomy with membrane peeling if vitreoretinal traction contributes; can hasten fluid clearance in refractory cases.

4. Subretinal Fluid Drainage
   Scleral or external drainage of accumulated fluid; immediate reattachment but reserved for complex detachments.

5. Scleral Buckling
   Episcleral silicone band to indent sclera; redistributes hydrostatic forces away from RPE, potentially reducing serous leaks.

---

Preventive Measures

1. Avoid systemic corticosteroids whenever possible Wikipedia.

2. Manage stress through meditation or counseling PMC.

3. Maintain consistent sleep (7–8 h/night) Cleveland Clinic.

4. Limit caffeine (<200 mg/day) Cleveland Clinic.

5. Moderate alcohol intake Cleveland Clinic.

6. Control systemic hypertension.

7. Treat obstructive sleep apnea if present.

8. Quit smoking.

9. Follow an antioxidant-rich diet ScienceDirect.

10. Schedule regular retinal examinations Sharon Heng.

---

When to See a Doctor

Seek prompt ophthalmic evaluation if you experience persistent metamorphopsia (wavy vision), central scotoma, decreased visual acuity beyond 3 months, sudden vision loss, bilateral involvement, or any recurrent symptoms—early intervention optimizes outcomes.

---

What to Do & What to Avoid

1. Adequate Sleep
   – Do: Keep regular bedtime/wake time Cleveland Clinic
   – Avoid: “Catch-up” sleep on weekends that disrupts circadian rhythm.

2. Stress Management
   – Do: Practice MBSR or guided imagery PMC
   – Avoid: High-pressure work sprints without breaks.

3. Medication Review
   – Do: Consult doctor before taking steroids Wikipedia
   – Avoid: Self-medicating with corticosteroid nasal sprays or creams.

4. Eye Protection
   – Do: Wear UV-blocking sunglasses outdoors
   – Avoid: Direct sun exposure without protection.

5. Caffeine Control
   – Do: Limit to 1–2 cups coffee daily Cleveland Clinic
   – Avoid: Energy drinks or excessive coffee.

6. Alcohol Intake
   – Do: Have no more than one standard drink per day Cleveland Clinic
   – Avoid: Binge drinking episodes.

7. Exercise
   – Do: Engage in moderate aerobic activity
   – Avoid: Strenuous Valsalva-inducing workouts.

8. Home Monitoring
   – Do: Use Amsler grid daily
   – Avoid: Ignoring new distortions.

9. Hydration
   – Do: Drink 1.5–2 L water daily
   – Avoid: Dehydration from excessive diuretics.

10. Smoking
    – Do: Maintain smoke-free status
    – Avoid: Any tobacco use.

---

Frequently Asked Questions

1. What exactly is Bacillary Layer Detachment?
   BLD is a split in the photoreceptor myoid zone visible on OCT, creating an intraretinal fluid cavity JournalAgentPubMed.

2. What symptoms does BLD cause?
   Patients commonly report blurred or wavy central vision (metamorphopsia), a gray or dark spot, and sometimes mild photopsia Wikipedia.

3. How is BLD diagnosed?
   High-resolution spectral-domain OCT shows a hypo-reflective cavity between the ELM and EZ, often with an overlying hyper-reflective band continuous with the EZ ScienceDirect.

4. What conditions are associated with BLD?
   Inflammatory (VKH), vascular (CSC, nAMD), infectious (toxoplasmosis), traumatic, and neoplastic choroidal lesions can all present with BLD JournalAgent.

5. Is BLD permanent?
   Most BLDs resolve within weeks to months, either spontaneously or with treatment; chronic or hemorrhagic BLD may lead to fibrosis.

6. What is the first-line treatment?
   Treating the underlying cause—e.g., half-dose PDT for chronic CSC or high-dose steroids for VKH—is the standard approach PLOS.

7. How long does treatment take?
   Resolution time varies: CSC-related BLD may clear in 2–4 months with PDT, while inflammatory BLD may resolve in 4–6 weeks with steroids.

8. Can BLD recur?
   Yes—up to 20–30% recurrence rates are reported, especially if systemic triggers (stress, steroids) are not managed.

9. Are there surgical options?
   PDT, focal laser, vitrectomy, and subretinal drainage are procedural choices for refractory cases.

10. What are the risks of treatment?
    Anti-VEGF may cause injection complications, PDT can induce choroidal ischemia, and systemic steroids have multisystem side effects.

11. Can diet help?
    Antioxidant-rich diets (omega-3s, lutein) support RPE health but are adjunctive.

12. When should I follow up?
    Monthly OCT scans initially, then every 3–6 months once stable.

13. Is low vision rehabilitation needed?
    If persistent scotomas impair daily tasks, referral to low-vision services is beneficial.

14. Can children get BLD?
    Rarely; most pediatric cases are traumatic or infectious.

15. Where can I learn more?
    Trusted resources include peer-reviewed journals, EyeWiki, and retina specialist societies.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 14, 2025.